JAGSONPAL PHARMACEUTICALS
Back to Cashflow Statement
|
JAGSONPAL PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹55 Cr | ₹35 Cr | ₹47 Cr | ₹6.91 Cr | ₹28 Cr |
What is the latest Cash Flow from Operating Activities ratio of JAGSONPAL PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹55 Cr |
| Mar2024 | ₹35 Cr |
| Mar2023 | ₹47 Cr |
| Mar2022 | ₹6.91 Cr |
| Mar2021 | ₹28 Cr |
How is Cash Flow from Operating Activities of JAGSONPAL PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹55 Cr | 57.25 | |
| Mar2024 | ₹35 Cr | -24.63 | |
| Mar2023 | ₹47 Cr | 574.79 | |
| Mar2022 | ₹6.91 Cr | -75.50 | |
| Mar2021 | ₹28 Cr | - | |
Compare Cash Flow from Operating Activities of peers of JAGSONPAL PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JAGSONPAL PHARMACEUTICALS | ₹1,518.7 Cr | 0.6% | -2% | -6.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,312.0 Cr | 0.8% | 6.3% | 18.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹213,879.0 Cr | 8.6% | 20.7% | 18.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹194,094.0 Cr | 1.7% | 9.4% | 38.5% | Stock Analytics | |
| CIPLA | ₹118,992.0 Cr | 4.5% | 1.2% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,787.4 Cr | -0.3% | -14.8% | -9.5% | Stock Analytics | |
JAGSONPAL PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JAGSONPAL PHARMACEUTICALS | 0.6% |
-2% |
-6.3% |
| SENSEX | 2.7% |
1.5% |
-5.6% |
You may also like the below Video Courses